Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Eden Research plc (LON:EDEN)’s stock price traded down 3.3% on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The stock has a 50-day simple moving average of GBX 3.88 and a 200-day simple moving average of GBX 3.95.

Insider Activity

In other news, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction on Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). 14.02% of the stock is currently owned by corporate insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.